ABL Diagnostics specializes in the development of software for collecting and processing medical databases, measuring the quality of care, diagnosing infectious diseases (AIDS, viral hepatitis and tuberculosis) by genotyping, and providing decision support for doctors and nurses, virology and microbiology laboratories, and researchers dealing with patients suffering from chronic and complex diseases. Export accounts for 69.7% of net sales.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change	Volume
06/26/06	€2.500	-3.10%	3,173
05/26/05	€2.580	+2.38%	7,728
04/26/04	€2.520	+2.44%	7,705
03/26/03	€2.460	+1.65%	1,966
31/26/31	€2.420	0.00%	3,241

Real-time Euronext Paris

More quotes

Income Statement and Estimates

More financial data

Annual profits - Rate of surprise

Company calendar

Market Closed - Euronext Paris Other stock markets 09:25:00 06/08/2026 pm IST			5-day change	1st Jan Change
2.500 ^EUR	-3.10%		+3.31%	-16.67%

23/07	French Court OKs ABL Diagnostics' Industrial Plan to Acquire Texcell	MT
23/07	ABL Diagnostics Société anonyme agreed to acquire Assets and Business Operations from Texcell SA for ?0.78 million.	CI

Market Cap	4.15Cr 4.78Cr 3.88Cr 3.55Cr 6.7Cr 455.1Cr 6.79Cr 45Cr 18Cr 227.38Cr 18Cr 18Cr 756.82Cr	P/E 2024	123x	P/E 2025	50x
Enterprise Value	4.24Cr 4.88Cr 3.97Cr 3.63Cr 6.85Cr 465.34Cr 6.94Cr 46Cr 18Cr 232.5Cr 18Cr 18Cr 773.85Cr	EV / Sales 2024	70,98,474x	EV / Sales 2025	61,85,843x
Free-Float	6.2%	Yield 2024	2.03%	Yield 2025	3.67%

23/07	French Court OKs ABL Diagnostics' Industrial Plan to Acquire Texcell	MT
23/07	ABL Diagnostics Société anonyme agreed to acquire Assets and Business Operations from Texcell SA for ?0.78 million.	CI
02/07	Abl Diagnostics Société Anonyme Approves Dividend Distribution for Fiscal Year 2025, Payable on July 7, 2026	CI
12/06	Abl Diagnostics Sa and Cdl Pharma Secure Multi-Year International Contract of Up to Eur 2.7 Million Through 2031	CI
12/06	ABL Diagnostics Signs Multi-year Contract to Provide Clinical Trial Services	MT
12/06	ABL Diagnostics Secures Multi-Year Contract with CDL Pharma
10/06	ABL Diagnostics Offers to Buy Texcell	MT
05/06	ABL divests block of ABL Diagnostics shares
02/06	ABL Diagnostics Société anonyme Provides Earnings Guidance for the Fiscal Year Ending December 31, 2026	CI
18/05	ABL Diagnostics Société anonyme Proposes Dividend for the Financial Year Ended December 31, 2025, Payable on July 7, 2026	CI
07/05	ABL Diagnostics Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2025	CI
14/11	Abl Diagnostics Appoints Eurobio Scientific as Exclusive Distributor for Its Vela Product Line in A Targeted Segment of the French Market	CI
02/25/02	ABL Diagnostics Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2025	CI

29/07	ABL Diagnostics: Sale of a New Block of Shares by Its Main Shareholder ABL	BU
27/07	ABL Diagnostics Announces Amendment to the Equity Line and Share Loan Agreement Between Its Main Shareholder ABL SA (Luxembourg) and Alumni Capital	BU
23/07	ABL Diagnostics Selected by the Évry Commercial Court to Acquire TEXCELL’s Operations	BU
22/07	ABL Diagnostics: Sale of a New Block of Shares by Its Main Shareholder ABL	BU
15/07	ABL Diagnostics Informed that its Reference Shareholder ABL Has Crossed Below the 95% Threshold	BU

ABL Diagnostics Share Price

Stocks

ABLD

FR001400AHX6

Medical Equipment, Supplies & Distribution

Valuation: ABL Diagnostics

Chart: ABL Diagnostics

Latest news : ABL Diagnostics

Press Releases: ABL Diagnostics

News in other languages: ABL Diagnostics

Quotes and Performance

Course Extremes

Managers and Directors: ABL Diagnostics

Latest insider transactions

Other Medical Equipment, Supplies & Distribution

Financials

Company Profile

Quotes

Income Statement and Estimates

Annual profits - Rate of surprise

29/07	ABL Diagnostics : Cession d'un nouveau bloc d'actions par son actionnaire principal ABL
27/07	ABL Diagnostics annonce la signature d'un avenant au contrat d'Equity Line et de prêt de titres entre son actionnaire principal ABL SA (Luxembourg) et Alumni Capital
23/07	ABL Diagnostics désignée par le Tribunal de commerce d'Évry pour la reprise des activités de TEXCELL
22/07	ABL Diagnostics : Cession d'un nouveau bloc d'actions par son actionnaire principal ABL
15/07	L'actionnaire de référence d'ABL Diagnostics allège ses positions

1 day	-3.10%
1 week	+3.31%
Current month	+3.31%
1 month	-6.72%
3 months	+8.70%
6 months	-25.60%
Current year	-16.67%

1 week	2.38	2.74
1 month	2.18	2.74
Current year	2.12	5
1 year	2.12	5
3 years	2.12	9.7
5 years	1.99	26
10 years	1.28	26

Director	Title	Age	Since
Noemie Sadoun CHM	Chairman	-	-
Laure Raffaelli BRD	Director/Board Member	-	-
Deborah Szafir BRD	Director/Board Member	-	-

Date	Insider	Type	Main position	Quantity	% Market Cap.
20/07/26	Advanced Biological Laboratories SA	Sell	Company	-65,616	0.4072%
06/07/26	Advanced Biological Laboratories SA	Sell	Company	-62,308	0.3867%
13/02/26	Advanced Biological Laboratories SA	Sell	Company	1,28,026	0.7945%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ABL DIAGNOSTICS	-3.10%	+3.31%	-42.92%	-71.59%	4.79Cr
ABBOTT LABORATORIES	+1.72%	+1.88%	-17.82%	-0.78%	18TCr
MEDTRONIC PLC	+0.12%	+0.54%	-3.57%	+1.71%	11TCr
CENCORA, INC.	+1.65%	+2.98%	+13.30%	+72.32%	6.17TCr
HOYA CORPORATION	-1.64%	+7.20%	+39.25%	+56.58%	5.5TCr
BECTON, DICKINSON AND COMPANY	+3.56%	+6.80%	+2.49%	-35.80%	4.7TCr
MEDLINE INC.	-4.66%	-9.85%	-	-	3.22TCr
DEXCOM, INC.	+0.53%	+11.64%	+8.93%	-31.21%	3.12TCr
WEST PHARMACEUTICAL SERVICES, INC.	-1.05%	+2.23%	+46.31%	-8.33%	2.47TCr
STERIS PLC	-1.03%	-0.29%	+4.22%	+1.92%	2.27TCr
Average	-0.41%	+1.75%	+5.57%	-1.69%	5.67TCr
Weighted average by Cap.	+0.55%	+0.19%	+1.79%	+8.96%

	2024	2025
Net sales	5.87 6.76 5.5 5.03 9.49 644.29 9.62 64.3 25.23 321.91 25.39 24.84 1.07T	7.97 9.18 7.46 6.82 12.88 874.39 13.05 87.26 34.25 436.88 34.46 33.72 1.45T
Net income	3L 3L 3L 2L 5L 3.13Cr 5L 31.24L 12.26L 1.56Cr 12.34L 12.07L 5.21Cr	10L 11.37L 9L 8L 15.96L 11Cr 16.16L 1.08Cr 42.42L 5.41Cr 42.69L 41.76L 18Cr
Net Debt	20.24L 23.32L 18.95L 17.34L 32.73L 22Cr 33.15L 2.22Cr 87.01L 11Cr 87.56L 85.66L 37Cr	9L 10.75L 9L 8L 15.08L 10Cr 15.28L 1.02Cr 40.1L 5.12Cr 40.35L 39.47L 17Cr